搜尋結果
2024年6月6日 · Ozempic ( semaglutide) is from a class of medicines called a glucagon-like peptide-1 (GLP-1) agonists ( incretin mimetics) that works by binding to GLP-1 receptors, which results in lower blood sugar levels and A1C levels and may also reduce your appetite to help weight loss.
- Senior Editorial Pharmacist
Medications for Rheumatoid Arthritis. Other names: Arthritis; Arthritis, Rheumatoid; RA. Rheumatoid arthritis is a long-term inflammatory condition that can affect the joints and other tissues and organs in the body.
Humira is used to treat many inflammatory conditions in adults, such as rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, plaque psoriasis, and a skin condition called hidradenitis suppurativa. Humira is also used in adults and children to treat Crohn's disease, juvenile idiopathic arthritis, ulcerative colitis and uveitis.
2024年6月11日 · What is adalimumab? Adalimumab ( Humira and others) is used to treat plaque psoriasis (Ps), Crohn's disease, ulcerative colitis, rheumatoid arthritis (RA), psoriatic arthritis (PsA), juvenile idiopathic arthritis, ankylosing spondylitis, and uveitis. Adalimumab works to reduce pain, inflammation, and skin symptoms in chronic autoimmune conditions.
New Drugs. Pipeline. Clinical Trials. FDA Alerts. Comprehensive and up-to-date drug news for both consumers and healthcare professionals. When Bills Become an Issue, Couples Stop Communicating. FRIDAY, July 4, 2024 -- If you and your partner fall silent when vexing money issues arise, new research suggests you are not alone. A team from Cornell...
Date of Approval: June 20, 2024. Treatment for: Paroxysmal Nocturnal Hemoglobinuria. PiaSky (crovalimab-akkz) is a complement C5 inhibitor for the treatment of paroxysmal nocturnal hemoglobinuria. FDA Approves PiaSky (crovalimab-akkz) for the Treatment of Paroxysmal Nocturnal Hemoglobinuria - June 24, 2024.
